ICH
MCID: HMR039
MIFTS: 62

Hemorrhage, Intracerebral (ICH)

Categories: Genetic diseases, Neuronal diseases

Aliases & Classifications for Hemorrhage, Intracerebral

MalaCards integrated aliases for Hemorrhage, Intracerebral:

Name: Hemorrhage, Intracerebral 58
Hemorrhage, Intracerebral, Susceptibility to 58 30 13 6 41
Intracerebral Hemorrhage 76 56 17
Hemorrhagic Stroke 76 56 44
Ich 58 77 76
Stroke, Hemorrhagic, Susceptibility to 58 6
Stroke, Hemorrhagic 58
Cerebral Hemorrhage 45
Brain Hemorrhage 74

Classifications:



External Ids:

OMIM 58 614519
MeSH 45 D002543
UMLS 74 C0553692

Summaries for Hemorrhage, Intracerebral

MedlinePlus : 44 A stroke is a medical emergency. There are two types - ischemic and hemorrhagic. Hemorrhagic stroke is the less common type. It happens when a blood vessel breaks and bleeds into the brain. Within minutes, brain cells begin to die. Causes include a bleeding aneurysm, an arteriovenous malformation (AVM), or an artery wall that breaks open. Symptoms of stroke are Sudden numbness or weakness of the face, arm or leg (especially on one side of the body) Sudden confusion, trouble speaking or understanding speech Sudden trouble seeing in one or both eyes Sudden trouble walking, dizziness, loss of balance or coordination Sudden severe headache with no known cause It is important to treat strokes as quickly as possible. With a hemorrhagic stroke, the first steps are to find the cause of bleeding in the brain and then control it. Surgery may be needed. Post-stroke rehabilitation can help people overcome disabilities caused by stroke damage. National Institute of Neurological Disorders and Stroke

MalaCards based summary : Hemorrhage, Intracerebral, also known as hemorrhage, intracerebral, susceptibility to, is related to cerebral hemorrhage and cerebral amyloid angiopathy, app-related, and has symptoms including seizures, tremor and angina pectoris. An important gene associated with Hemorrhage, Intracerebral is COL4A1 (Collagen Type IV Alpha 1 Chain), and among its related pathways/superpathways are Neuroscience and Microglia Activation During Neuroinflammation: Overview. The drugs Aspirin and Probucol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and kidney, and related phenotypes are cardiovascular system and growth/size/body region

UniProtKB/Swiss-Prot : 76 Intracerebral hemorrhage: A pathological condition characterized by bleeding into one or both cerebral hemispheres including the basal ganglia and the cerebral cortex. It is often associated with hypertension and craniocerebral trauma. Intracerebral bleeding is a common cause of stroke.

Wikipedia : 77 The Crawford expedition was a campaign on the western front of the American Revolutionary War, and one... more...

Description from OMIM: 614519

Related Diseases for Hemorrhage, Intracerebral

Diseases related to Hemorrhage, Intracerebral via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 465)
# Related Disease Score Top Affiliating Genes
1 cerebral hemorrhage 33.8 APP CST3
2 cerebral amyloid angiopathy, app-related 33.6 APP CST3
3 familial porencephaly 32.1 COL4A1 COL4A2
4 amyloidosis 30.4 APOE APP CST3
5 porencephaly 29.9 COL4A1 COL4A2
6 chronic kidney failure 29.9 ACE CST3 HMGCR
7 ischemia 29.9 ACE APP PLAT
8 hereditary cerebral amyloid angiopathy 29.9 APP CST3
9 granulomatous angiitis 29.9 ACE CST3
10 hemiplegia 29.7 COL4A1 COL4A2
11 ischemic heart disease 29.6 ACE APOE
12 kidney disease 29.5 ACE APOE CST3 HMGCR
13 cerebral amyloid angiopathy, cst3-related 29.5 APOE APP CST3
14 carotid stenosis 29.3 ACE APOE
15 lipid metabolism disorder 29.3 ACE APOE HMGCR
16 coronary artery anomaly 29.3 ACE HMGCR PLAT
17 arteriosclerosis 29.3 ACE APOE HMGCR
18 hypertension, essential 29.3 ACE CST3 PLAT
19 arteries, anomalies of 29.3 ACE APOE PLAT
20 aphasia 29.2 APOE APP
21 cerebrovascular disease 29.0 ACE APOE APP COL4A1 PLAT
22 heart disease 28.9 ACE APOE CST3 PLAT
23 diabetes mellitus, noninsulin-dependent 28.9 ACE APOE HMGCR PLAT
24 stroke, ischemic 28.8 ACE APOE CST3 HMGCR PLAT
25 myocardial infarction 28.8 ACE APOE CST3 HMGCR PLAT
26 vascular disease 28.6 ACE APOE CST3 HMGCR PLAT
27 brain ischemia 11.5
28 eclampsia 11.4
29 hyperaldosteronism, familial, type i 11.4
30 factor vii deficiency 11.2
31 moyamoya disease 6 with or without achalasia 11.2
32 cerebral cavernous malformation, familial 11.2
33 cerebral cavernous malformations 2 11.0
34 cavernous hemangioma 11.0
35 cerebellar degeneration 11.0
36 col4a1-related brain small-vessel disease 11.0
37 vascular erectile tumor 11.0
38 congenital vascular cavernous malformations 11.0
39 familial hemangioma 11.0
40 cerebral arteriosclerosis 11.0
41 cerebral cavernous malformations 11.0
42 thrombocytopenia 1 11.0
43 angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps 10.3 COL4A1 COL4A2
44 corneal dystrophy, posterior polymorphous, 3 10.3 COL4A1 COL4A2
45 anterolateral myocardial infarction 10.2 ACE PLAT
46 intermediate coronary syndrome 10.2 ACE PLAT
47 marek disease 10.2 ACE HMGCR
48 hepatorenal syndrome 10.2 ACE CST3
49 systolic heart failure 10.2 ACE CST3
50 angina pectoris 10.2 ACE PLAT

Graphical network of the top 20 diseases related to Hemorrhage, Intracerebral:



Diseases related to Hemorrhage, Intracerebral

Symptoms & Phenotypes for Hemorrhage, Intracerebral

Clinical features from OMIM:

614519

UMLS symptoms related to Hemorrhage, Intracerebral:


seizures, tremor, angina pectoris, edema, back pain, pain, headache, chest pain, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Hemorrhage, Intracerebral:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.08 ACE APOE APP CCM2 COL4A1 COL4A2
2 growth/size/body region MP:0005378 10.06 ACE APOE APP CCM2 COL4A1 COL4A2
3 homeostasis/metabolism MP:0005376 10.06 ACE APOE APP CCM2 COL4A1 COL4A2
4 hematopoietic system MP:0005397 9.98 ACE APOE APP CCM2 COL4A1 COL4A2
5 mortality/aging MP:0010768 9.97 ACE APOE APP CCM2 COL4A1 COL4A2
6 immune system MP:0005387 9.91 ACE APOE APP CCM2 COL4A1 COL4A2
7 muscle MP:0005369 9.8 APOE APP CCM2 COL4A1 COL4A2 CST3
8 nervous system MP:0003631 9.7 APOE APP CCM2 COL4A1 COL4A2 CST3
9 reproductive system MP:0005389 9.5 ACE APOE APP COL4A1 COL4A2 CST3
10 vision/eye MP:0005391 9.02 APOE CCM2 COL4A1 COL4A2 PLAT

Drugs & Therapeutics for Hemorrhage, Intracerebral

Drugs for Hemorrhage, Intracerebral (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 388)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
2
Probucol Approved, Investigational Phase 4 23288-49-5 4912
3
Cilostazol Approved, Investigational Phase 4,Not Applicable 73963-72-1 2754
4
Enoxaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 55985-32-5 4474
6
Dalteparin Approved Phase 4,Phase 2,Not Applicable 9005-49-6
7
Nadroparin Approved, Investigational Phase 4
8
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 46507594 772
9
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
10
Cisatracurium Approved Phase 4,Not Applicable 96946-41-7
11
Phylloquinone Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 84-80-0
12
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 54678486 6691
13 Menaquinone Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 1182-68-9
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
15
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1401-55-4
16
Simvastatin Approved Phase 4,Phase 2,Not Applicable 79902-63-9 54454
17
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
18
Midazolam Approved, Illicit Phase 4,Not Applicable 59467-70-8 4192
19
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
20
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
21
Etomidate Approved Phase 4,Not Applicable 33125-97-2 667484 36339
22
Edoxaban Approved Phase 4,Phase 2,Phase 3,Not Applicable 480449-70-5
23
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 6251 453
24
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
25
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
26
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 120202-66-6, 113665-84-2 60606
27
Caffeine Approved Phase 4,Phase 1,Phase 2 58-08-2 2519
28
Sodium Citrate Approved, Investigational Phase 4 68-04-2
29
Ticagrelor Approved Phase 4 274693-27-5 9871419
30
Amlodipine Approved Phase 4,Phase 3,Not Applicable 88150-42-9 2162
31
Angiotensin II Approved, Investigational Phase 4,Phase 3,Not Applicable 11128-99-7, 68521-88-0, 4474-91-3 172198
32
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
33
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
34
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 5282452 6366718
35
Ezetimibe Approved Phase 4 163222-33-1 150311
36
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
37
Succinylcholine Approved Phase 4,Not Applicable 306-40-1 5314
38
Atorvastatin Approved Phase 4,Not Applicable 134523-00-5 60823
39
Nitroprusside Approved, Investigational Phase 4,Phase 3,Not Applicable 15078-28-1 11963622
40
Esmolol Approved Phase 4,Phase 3,Not Applicable 103598-03-4, 81147-92-4 59768
41
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Not Applicable 10102-43-9 145068
42
Betamethasone Approved, Vet_approved Phase 4,Not Applicable 378-44-9 9782
43
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
44
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 5311068 68602
45
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
46
Desflurane Approved Phase 4 57041-67-5 42113
47
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
48
Losartan Approved Phase 4 114798-26-4 3961
49
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
50
Tirofiban Approved Phase 4 144494-65-5 60947

Interventional clinical trials:

(show top 50) (show all 547)
# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
4 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
7 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
8 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
9 The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Unknown status NCT02870764 Phase 4 Dan-shen extract;Placebo
10 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
11 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
12 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
13 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
14 Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study Completed NCT03847883 Phase 4 Intravenous Solution Ateplase
15 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
16 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed NCT00234065 Phase 4 Cilostazol;Aspirin
17 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
18 Clopidogrel for Acute Ischaemia of Recent Onset Completed NCT02776540 Phase 4 Clopidogrel;Aspirin
19 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
20 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
21 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
22 A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting Completed NCT02330640 Phase 4 ticagrelor;clopidogrel;asprin
23 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
24 Danhong Injection in the Treatment of Acute Ischemic Stroke Completed NCT01677208 Phase 4 Danhong injection;placebo
25 Cilostazol Stroke Prevention Study for Antiplatelet Combination Completed NCT01995370 Phase 4 aspirin;clopidogrel;cilostazol
26 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
27 Continuous Glucose Monitoring and Preterm Infants Completed NCT02583776 Phase 4
28 Study of Heart and Renal Protection Completed NCT00125593 Phase 4 Simvastatin 20 mg;Ezetimibe 10mg;Placebo
29 Danhong Injection in the Treatment of Chronic Stable Angina Completed NCT01681316 Phase 4 Danhong injection;Placebo
30 Study of Antithrombotic Treatment After IntraCerebral Haemorrhage Recruiting NCT03186729 Phase 4 Antithrombotic Agent
31 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
32 Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial Recruiting NCT03772847 Phase 4 ginkgolide
33 Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes Recruiting NCT03264352 Phase 4 Allisartan Isoproxil;Amlodipine 5mg;Hydrochlorothiazide 25 mg;Allisartan Isoproxil placebo;Amlodipine placebo;Hydrochlorothiazide placebo
34 Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke Recruiting NCT03661411 Phase 4 Aspirin;Clopidogrel 75mg;Alteplase
35 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
36 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Recruiting NCT03417388 Phase 4 High dose potent statin;ACE-I (lisinopril) or ARB (losartan);Aspirin
37 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
38 ASCEND: A Study of Cardiovascular Events iN Diabetes Active, not recruiting NCT00135226 Phase 4 Aspirin;Omega-3 Ethyl Esters;Placebo Aspirin;Placebo Omega-3 Ethyl Esters
39 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
40 Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS) Not yet recruiting NCT03743103 Phase 4 Brevibloc, 10 Mg/mL Intravenous Solution;Nitroprusside, Sodium
41 EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) Not yet recruiting NCT03950076 Phase 4 Edoxaban
42 Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction Not yet recruiting NCT03797729 Phase 4 Tirofiban;Normal saline
43 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
44 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
45 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Withdrawn NCT01042574 Phase 4 Clevidipine butyrate
46 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
47 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
48 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
49 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
50 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3

Search NIH Clinical Center for Hemorrhage, Intracerebral

Cochrane evidence based reviews: cerebral hemorrhage

Genetic Tests for Hemorrhage, Intracerebral

Genetic tests related to Hemorrhage, Intracerebral:

# Genetic test Affiliating Genes
1 Hemorrhage, Intracerebral, Susceptibility to 30 ACE COL4A1 COL4A2

Anatomical Context for Hemorrhage, Intracerebral

MalaCards organs/tissues related to Hemorrhage, Intracerebral:

42
Brain, Heart, Kidney, Bone, Cortex, Liver, Eye

Publications for Hemorrhage, Intracerebral

Articles related to Hemorrhage, Intracerebral:

(show top 50) (show all 745)
# Title Authors Year
1
Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage. ( 31040201 )
2019
2
Trends in the Incidence and Treatment of Cerebrovascular Diseases in Korea : Part I. Intracranial Aneurysm, Intracerebral Hemorrhage, and Arteriovenous Malformation. ( 31064041 )
2019
3
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage. ( 30869568 )
2019
4
Tolvaptan attenuated brain edema in experimental intracerebral hemorrhage. ( 30703371 )
2019
5
Adipose-derived mesenchymal stem cells stereotactic transplantation alleviate brain edema from intracerebral hemorrhage. ( 30963640 )
2019
6
AdipoRon Protects Against Secondary Brain Injury After Intracerebral Hemorrhage via Alleviating Mitochondrial Dysfunction: Possible Involvement of AdipoR1-AMPK-PGC1α Pathway. ( 30982205 )
2019
7
Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. ( 30923023 )
2019
8
Exploration of MST1-Mediated Secondary Brain Injury Induced by Intracerebral Hemorrhage in Rats via Hippo Signaling Pathway. ( 30941717 )
2019
9
Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-κB)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage. ( 30855024 )
2019
10
Inhibition of EPAC2 Attenuates Intracerebral Hemorrhage-Induced Secondary Brain Injury via the p38/BIM/Caspase-3 Pathway. ( 30607901 )
2019
11
Brain Ceruloplasmin Expression After Experimental Intracerebral Hemorrhage and Protection Against Iron-Induced Brain Injury. ( 30315404 )
2019
12
Minocycline attenuates brain injury and iron overload after intracerebral hemorrhage in aged female rats. ( 29879529 )
2019
13
Silent Intracerebral Hemorrhage in Patients Randomized to Stenting or Endarterectomy for Symptomatic Carotid Stenosis. ( 30732448 )
2019
14
Original Intracerebral Hemorrhage Score for the Prediction of Short-Term Mortality in Cerebral Hemorrhage: Systematic Review and Meta-Analysis. ( 30889025 )
2019
15
Quality of life and depression 3 months after intracerebral hemorrhage. ( 30907075 )
2019
16
Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage. ( 30922067 )
2019
17
Editors' note: Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage. ( 30988090 )
2019
18
Reader response: Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage. ( 30988091 )
2019
19
Transfusion of Resting Platelets Reduces Brain Hemorrhage After Intracerebral Hemorrhage and tPA-Induced Hemorrhage After Cerebral Ischemia. ( 31024246 )
2019
20
Progressive Cerebral Ischemia and Intracerebral Hemorrhage after Indirect Revascularization for a Patient with Cerebral Proliferative Angiopathy. ( 30737070 )
2019
21
Intractable Repeated Intracerebral Hemorrhage Due to Primary Dural Leiomyosarcoma: Case Report and Literature Review. ( 30391601 )
2019
22
Leukemia Inhibitory Factor Decreases Neurogenesis and Angiogenesis in a Rat Model of Intracerebral Hemorrhage. ( 31016525 )
2019
23
Corrigendum to Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study [Journal of Stroke and Cerebrovascular Diseases Volume 28, Issue 2, February 2019, Pages 267-275]. ( 30745231 )
2019
24
Modulating acute neuroinflammation in intracerebral hemorrhage: the potential promise of currently approved medications for multiple sclerosis. ( 30702002 )
2019
25
Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort Study. ( 30385221 )
2019
26
A troponin study on patients with ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage: Type II myocardial infarction is significantly associated with stroke severity, discharge disposition and mortality. ( 31014907 )
2019
27
Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large Prospective cohort and preliminary meta-analysis. ( 30785378 )
2019
28
Intracerebral hemorrhage due to cerebral venous thrombosis during posterior cervical decompression and fusion for traumatic cervical cord injury: A case report. ( 31083201 )
2019
29
Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. ( 30308696 )
2019
30
New Silent Cerebral Infarction in Patients with Acute Non-Cerebral Amyloid Angiopathy Intracerebral Hemorrhage as a Predictor of Recurrent Cerebrovascular Events. ( 30640895 )
2019
31
Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage. ( 30836997 )
2019
32
Acute Management of Hypertension Following Intracerebral Hemorrhage. ( 30807338 )
2019
33
Management of Chronic Hypertension Following Intracerebral Hemorrhage. ( 30807339 )
2019
34
An 85-Gene Coexpression Module for Progression of Hypertension-Induced Spontaneous Intracerebral Hemorrhage. ( 30839233 )
2019
35
Novel Insights into MSK1 Phosphorylation by MRKβ in Intracerebral Hemorrhage-Induced Neuronal Apoptosis. ( 30744416 )
2019
36
Obesity Paradox in Intracerebral Hemorrhage. ( 30879440 )
2019
37
Asymptomatic Intracerebral Hemorrhage May Worsen Clinical Outcomes in Acute Ischemic Stroke Patients Undergoing Thrombectomy. ( 30926220 )
2019
38
Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults. ( 30858617 )
2019
39
Intracerebral hemorrhage research, no longer the bridesmaid to ischemic stroke. ( 30870134 )
2019
40
Dasatinib Re-initiation after Post-stroke Thrombolysis Associated with Symptomatic Intracerebral Hemorrhage. ( 30797908 )
2019
41
Renal Impairment Is Associated with Intracerebral Hemorrhage after Mechanical Thrombectomy in Vertebrobasilar Stroke. ( 30783049 )
2019
42
Does High Cerebral Microbleed Burden Increase the Risk of Intracerebral Hemorrhage After Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke? ( 30586035 )
2019
43
Associations of Anemia With Outcomes in Patients With Spontaneous Intracerebral Hemorrhage: A Meta-Analysis. ( 31105636 )
2019
44
Primary Intraparenchymal Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma Presenting with Intracerebral Hemorrhage: A Case Report. ( 31062533 )
2019
45
Antiepileptic Drugs to Prevent Seizures After Spontaneous Intracerebral Hemorrhage. ( 30935318 )
2019
46
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels as a Biomarker of Acute Intracerebral Hemorrhage. ( 30442557 )
2019
47
Association of Diabetes and Glycated Hemoglobin With the Risk of Intracerebral Hemorrhage: A Population-Based Cohort Study. ( 30728223 )
2019
48
Determination of serum neutrophil gelatinase-associated lipocalin as a prognostic biomarker of acute spontaneous intracerebral hemorrhage. ( 30771300 )
2019
49
Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials. ( 30910581 )
2019
50
Probable Catastrophic Antiphospholipid Syndrome with Intracerebral Hemorrhage Secondary to Epstein-Barr Viral Infection. ( 28357636 )
2018

Variations for Hemorrhage, Intracerebral

UniProtKB/Swiss-Prot genetic disease variations for Hemorrhage, Intracerebral:

76
# Symbol AA change Variation ID SNP ID
1 COL4A1 p.Pro352Leu VAR_073810 rs200786329
2 COL4A1 p.Arg538Gly VAR_073811 rs397514624

ClinVar genetic disease variations for Hemorrhage, Intracerebral:

6 (show all 18)
# Gene Variation Type Significance SNP ID Assembly Location
1 ACE NM_000789.3(ACE): c.2306-117_2306-116insAF118569.1: g.14094_14382 insertion risk factor GRCh37 Chromosome 17, 61565892: 61565893
2 ACE NM_000789.3(ACE): c.2306-117_2306-116insAF118569.1: g.14094_14382 insertion risk factor GRCh38 Chromosome 17, 63488531: 63488532
3 COL4A2 NM_001846.3(COL4A2): c.3368A> G (p.Glu1123Gly) single nucleotide variant risk factor rs117412802 GRCh37 Chromosome 13, 111143601: 111143601
4 COL4A2 NM_001846.3(COL4A2): c.3368A> G (p.Glu1123Gly) single nucleotide variant risk factor rs117412802 GRCh38 Chromosome 13, 110491254: 110491254
5 COL4A2 NM_001846.3(COL4A2): c.3448C> A (p.Gln1150Lys) single nucleotide variant Likely benign rs62621875 GRCh37 Chromosome 13, 111143681: 111143681
6 COL4A2 NM_001846.3(COL4A2): c.3448C> A (p.Gln1150Lys) single nucleotide variant Likely benign rs62621875 GRCh38 Chromosome 13, 110491334: 110491334
7 COL4A2 NM_001846.3(COL4A2): c.5068G> A (p.Ala1690Thr) single nucleotide variant Likely benign rs201105747 GRCh37 Chromosome 13, 111164467: 111164467
8 COL4A2 NM_001846.3(COL4A2): c.5068G> A (p.Ala1690Thr) single nucleotide variant Likely benign rs201105747 GRCh38 Chromosome 13, 110512120: 110512120
9 COL4A1 NM_001845.5(COL4A1): c.1055C> T (p.Pro352Leu) single nucleotide variant Uncertain significance rs200786329 GRCh37 Chromosome 13, 110853814: 110853814
10 COL4A1 NM_001845.5(COL4A1): c.1055C> T (p.Pro352Leu) single nucleotide variant Uncertain significance rs200786329 GRCh38 Chromosome 13, 110201467: 110201467
11 COL4A1 NM_001845.5(COL4A1): c.1612C> G (p.Arg538Gly) single nucleotide variant risk factor rs397514624 GRCh37 Chromosome 13, 110839601: 110839601
12 COL4A1 NM_001845.5(COL4A1): c.1612C> G (p.Arg538Gly) single nucleotide variant risk factor rs397514624 GRCh38 Chromosome 13, 110187254: 110187254
13 COL4A1 NM_001845.5(COL4A1): c.1588C> T (p.Pro530Ser) single nucleotide variant Uncertain significance rs145172612 GRCh37 Chromosome 13, 110839625: 110839625
14 COL4A1 NM_001845.5(COL4A1): c.1588C> T (p.Pro530Ser) single nucleotide variant Uncertain significance rs145172612 GRCh38 Chromosome 13, 110187278: 110187278
15 COL4A1 NM_001845.4(COL4A1): c.7C> A (p.Pro3Thr) single nucleotide variant Uncertain significance rs751749989 GRCh37 Chromosome 13, 110959368: 110959368
16 COL4A1 NM_001845.4(COL4A1): c.7C> A (p.Pro3Thr) single nucleotide variant Uncertain significance rs751749989 GRCh38 Chromosome 13, 110307021: 110307021
17 COL4A1 NM_001845.5(COL4A1): c.2093A> G (p.Lys698Arg) single nucleotide variant Uncertain significance rs375318302 GRCh38 Chromosome 13, 110182995: 110182995
18 COL4A1 NM_001845.5(COL4A1): c.2093A> G (p.Lys698Arg) single nucleotide variant Uncertain significance rs375318302 GRCh37 Chromosome 13, 110835342: 110835342

Expression for Hemorrhage, Intracerebral

Search GEO for disease gene expression data for Hemorrhage, Intracerebral.

Pathways for Hemorrhage, Intracerebral

GO Terms for Hemorrhage, Intracerebral

Cellular components related to Hemorrhage, Intracerebral according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.85 ACE APOE APP COL4A2 CST3 PLAT
2 extracellular region GO:0005576 9.7 ACE APOE APP COL4A1 COL4A2 CST3
3 extracellular matrix GO:0031012 9.58 APOE COL4A1 COL4A2
4 collagen-containing extracellular matrix GO:0062023 9.56 APOE COL4A1 COL4A2 PLAT
5 extracellular space GO:0005615 9.5 ACE APOE APP COL4A1 COL4A2 CST3
6 collagen type IV trimer GO:0005587 9.32 COL4A1 COL4A2
7 endoplasmic reticulum lumen GO:0005788 9.02 APOE APP COL4A1 COL4A2 CST3

Biological processes related to Hemorrhage, Intracerebral according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 post-translational protein modification GO:0043687 9.69 APOE APP CST3
2 negative regulation of gene expression GO:0010629 9.61 ACE APOE APP
3 cellular protein metabolic process GO:0044267 9.58 APOE APP CST3
4 extracellular matrix organization GO:0030198 9.54 APP COL4A1 COL4A2
5 visual learning GO:0008542 9.49 APP HMGCR
6 cholesterol biosynthetic process GO:0006695 9.48 APOE HMGCR
7 negative regulation of MAP kinase activity GO:0043407 9.46 APOE HMGCR
8 negative regulation of proteolysis GO:0045861 9.32 CST3 PLAT
9 collagen-activated tyrosine kinase receptor signaling pathway GO:0038063 9.26 COL4A1 COL4A2
10 negative regulation of long-term synaptic potentiation GO:1900272 9.16 APOE APP
11 cholesterol metabolic process GO:0008203 9.13 APOE APP HMGCR
12 positive regulation of amyloid fibril formation GO:1905908 8.62 APOE APP

Molecular functions related to Hemorrhage, Intracerebral according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular matrix structural constituent conferring tensile strength GO:0030020 8.62 COL4A1 COL4A2

Sources for Hemorrhage, Intracerebral

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....